(Date:12/1/2009)...t Software agrees to migrate their Microsoft Dynam...ts) to Synergy Business Solutions to maintain qual...A (PRWEB) December 1, 2009 -- Synergy Business Sol...ft Dynamics SL practice of Congruent Software, a B... was necessary due to a change in Congruent Softwa...
(Date:12/1/2009)...c. 1 Aethlon Medical, In... it will present at the LD MICRO Conference on Thu...Luxe Hotel in Los Angeles. Aethlon Medical,s Chair...ate overview and will provide an update on the com... Hemopurifier®, a first-in-class artificial a...
(Date:12/1/2009)...H VANCOUVER, British Columbia, Dec. 1 /PRNewswire-... subsidiary of The Dow Chemical Company (NYSE: D...ed the signing of a research and commercial licens...oSciences with access to Agrisoma,s proprietary En...ve basis in major food crops, and on a non-exclusi...
(Date:12/1/2009)... Medizone International,...hat in tests involving its proprietary AsepticSure...ontamination barriers, this time with two very dif...ile and Bacillis subtilis. These results clearly e...oricidal technology. "The implications of a 6.7 lo...
Breaking Biology Technology:Synergy Business Solutions Acquires the Microsoft Dynamics SL Practice of Congruent Software, Inc. 2Synergy Business Solutions Acquires the Microsoft Dynamics SL Practice of Congruent Software, Inc. 3Aethlon Medical to Present at LD MICRO Conference on December 3, 2009 2Dow AgroSciences, Agrisoma Biosciences Announce Research and Commercial License Option Agreement for Agricultural Crops 2Dow AgroSciences, Agrisoma Biosciences Announce Research and Commercial License Option Agreement for Agricultural Crops 3Medizone International Takes Aim at the Bioterrorism Countermeasures Arena 2... DC A new analysis by the Project on Emerging Nan...s are investing nearly twice as much as the U.S. i...tial risks of nanotechnology. The analysis also hi...al governments nanotechnology risk-research invest...nt of nanotechnology risk-relevant projects identi...
... April 21 Boston Scientific,Corporation (NYSE: B...st,quarter ended March 31, 2008, as well as guidan...the second quarter of 2008., First quarter highl...nd adjusted EPS of $0.24 -- Improved earnings thr...ntained leading position in the worldwide drug-elu...
...erence Call Today at 5:00 p.m., CAMBRIDGE, Mass.,...nounced today that the FDA has informed the,compan...fa) produced at the,160L bioreactor scale and Myoz...ed as two different products because of difference... Currently, Genzyme has U.S.,approval to sell Myoz...
Other Biology Technology:Europe spends nearly twice as much as US on nanotech risk research 2Boston Scientific Announces Results for First Quarter Ended March 31, 2008 2Boston Scientific Announces Results for First Quarter Ended March 31, 2008 3Boston Scientific Announces Results for First Quarter Ended March 31, 2008 4Boston Scientific Announces Results for First Quarter Ended March 31, 2008 5Boston Scientific Announces Results for First Quarter Ended March 31, 2008 6Boston Scientific Announces Results for First Quarter Ended March 31, 2008 7Boston Scientific Announces Results for First Quarter Ended March 31, 2008 8Boston Scientific Announces Results for First Quarter Ended March 31, 2008 9Boston Scientific Announces Results for First Quarter Ended March 31, 2008 10Boston Scientific Announces Results for First Quarter Ended March 31, 2008 11Boston Scientific Announces Results for First Quarter Ended March 31, 2008 12Boston Scientific Announces Results for First Quarter Ended March 31, 2008 13Boston Scientific Announces Results for First Quarter Ended March 31, 2008 14Boston Scientific Announces Results for First Quarter Ended March 31, 2008 15Boston Scientific Announces Results for First Quarter Ended March 31, 2008 16Boston Scientific Announces Results for First Quarter Ended March 31, 2008 17Boston Scientific Announces Results for First Quarter Ended March 31, 2008 18Genzyme Provides Update on Myozyme(R) Manufacturing 2Genzyme Provides Update on Myozyme(R) Manufacturing 3Genzyme Provides Update on Myozyme(R) Manufacturing 4Genzyme Provides Update on Myozyme(R) Manufacturing 5Chaps Cell Extract Buffer (10X) from Cell Signaling Technology
Mouse Anti-TGE Virus peplomer Monoclonal Antibody, Unconjugated, Clone 1Q17 from Abcam
Mouse Anti-Human B3GALT2 Polyclonal Antibody, Unconjugated from ABR-Affinity BioReagents
Rabbit Anti-Lck, phospho (Tyr192) Polyclonal Antibody, Unconjugated from Abcam
Biology Products: